Proteome Sciences to Commercialize Two Protein Biomarker Assays for Alzheimer's Disease

The assays use multiple-reaction-monitoring mass spectrometry to measure the level of proteins associated with the disease and could be useful as diagnostic tests or research tools, said a company official.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.